- Home
- RVPH vs EBON Comparison
RVPH vs EBON Comparison
Compare RVPH & EBON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVPH
- EBON
- Stock Information
- Founded
- RVPH 2006
- EBON 2010
- Country
- RVPH United States
- EBON China
- Employees
- RVPH N/A
- EBON N/A
- Industry
- RVPH Biotechnology: Pharmaceutical Preparations
- EBON Semiconductors
- Sector
- RVPH Health Care
- EBON Technology
- Exchange
- RVPH Nasdaq
- EBON Nasdaq
- Market Cap
- RVPH 26.6M
- EBON 25.3M
- IPO Year
- RVPH N/A
- EBON 2020
- Fundamental
- Price
- RVPH $0.54
- EBON $4.09
- Analyst Decision
- RVPH Strong Buy
- EBON
- Analyst Count
- RVPH 5
- EBON 0
- Target Price
- RVPH $8.00
- EBON N/A
- AVG Volume (30 Days)
- RVPH 2.8M
- EBON 11.7K
- Earning Date
- RVPH 08-14-2025
- EBON 08-15-2025
- Dividend Yield
- RVPH N/A
- EBON N/A
- EPS Growth
- RVPH N/A
- EBON N/A
- EPS
- RVPH N/A
- EBON N/A
- Revenue
- RVPH N/A
- EBON $7,337,066.00
- Revenue This Year
- RVPH N/A
- EBON N/A
- Revenue Next Year
- RVPH N/A
- EBON N/A
- P/E Ratio
- RVPH N/A
- EBON N/A
- Revenue Growth
- RVPH N/A
- EBON 104.28
- 52 Week Low
- RVPH $0.30
- EBON $3.00
- 52 Week High
- RVPH $4.28
- EBON $10.94
- Technical
- Relative Strength Index (RSI)
- RVPH 61.01
- EBON 48.11
- Support Level
- RVPH $0.40
- EBON $3.80
- Resistance Level
- RVPH $0.48
- EBON $4.19
- Average True Range (ATR)
- RVPH 0.05
- EBON 0.25
- MACD
- RVPH 0.01
- EBON -0.04
- Stochastic Oscillator
- RVPH 58.53
- EBON 41.43
About RVPH Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.
About EBON Ebang International Holdings Inc.
Ebang International Holdings Inc is a blockchain technology and Fintech company, that has ASIC chip design capability. Its business is ASIC chip design and Telecommunication. It operates in a single segment selling bitcoin mining machines and related accessories, telecommunication products, providing cryptocurrency exchange services, management and maintenance services, and cross-border payment and foreign exchange services and rental services. Its geographic regions are Mainland China, and Australia.